EpCAM/CD3-Bispecific T-cell engaging antibody MT110 eliminates primary human pancreatic cancer stem cells
about
EpCAM/CD3-Bispecific T-cell engaging antibody MT110 eliminates primary human pancreatic cancer stem cells
description
scientific article published on 17 November 2011
@en
wetenschappelijk artikel
@nl
name
EpCAM/CD3-Bispecific T-cell en ...... n pancreatic cancer stem cells
@en
EpCAM/CD3-Bispecific T-cell en ...... n pancreatic cancer stem cells
@nl
type
label
EpCAM/CD3-Bispecific T-cell en ...... n pancreatic cancer stem cells
@en
EpCAM/CD3-Bispecific T-cell en ...... n pancreatic cancer stem cells
@nl
prefLabel
EpCAM/CD3-Bispecific T-cell en ...... n pancreatic cancer stem cells
@en
EpCAM/CD3-Bispecific T-cell en ...... n pancreatic cancer stem cells
@nl
P2093
P1476
EpCAM/CD3-Bispecific T-cell en ...... n pancreatic cancer stem cells
@en
P2093
Christopher Heeschen
Jorge Dorado
Patrick A Baeuerle
P304
P356
10.1158/1078-0432.CCR-11-1270
P577
2011-11-17T00:00:00Z